In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...

Votoplam (PTC518) for Huntington's Disease shows promising phase 2 results; a key FDA meeting in Q4 2025 could enable ...

A first-in-class, brain-penetrant sGC stimulator, zagociguat is hypothesized to rebalance dysregulated cellular pathways in MELAS. By restoring cellular functions that support mitochondria, zagociguat ...

In April 2025 , Northstrive Biosciences announced it received preliminary feedback from the FDA on its planned Type B pre-IND ...

King’s Entrepreneurship Lab and Founders at the University of Cambridge have unveiled the first SPARK 1.0 incubator cohort.

The systematic review and meta-analysis of studies from 51 countries also found that 57% of antibiotic prescriptions in primary care were inappropriate.

The average dividend yield in the S&P 500 Index remains low at around 1.3%. As a result, many stocks have lower dividend ...

The Business Research Company The Business Research Company's Bruton's Tyrosine Kinase (BTK) Inhibitor Global Market Report 2025 – Market S ...

In vivo CAR T-cell therapies promise to revolutionize cancer treatment, enhancing access and reducing costs while addressing ...

Assessment of feasibility for use of Parsortix derived circulating tumour cell (CTC) DNA with Myriad Genetics' existing ...